Enimmune Corp (6564)

TPEX

Currency in TWD

14.90

-0.40(-2.61%)

Closed·30/10

Fair Value

Unlock Value

Day's Range

14.65

15.25

52 wk Range

14.65

16.05

6564 Income Statement

Assess the Enimmune income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 6564 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

109.82

188.42

43.49

39.92

48.19

Total Revenues Growth

aa.aa

+380.08%

+71.56%

-76.92%

-8.23%

+20.74%

Cost Of Revenues

aa.aa

71.1

167.57

66.87

25.69

40.18

Gross Profit

aa.aa

38.72

20.84

-23.37

14.23

8.02

Gross Profit Growth

aa.aa

+371.14%

-46.18%

-212.14%

+160.87%

-43.65%

Gross Profit Margin %

aa.aa

35.26%

11.06%

-53.74%

35.64%

16.63%

Other Operating Expenses, Total

aa.aa

97.39

307.26

220.1

165.37

193.26

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.1%	+215.48%	-28.37%	-24.87%	+16.87%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	54.76	247.38	139.27	84.95	117.13
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	42.64	59.88	80.83	80.42	76.13
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-58.67

-286.42

-243.48

-151.14

-185.24

Operating Income Growth

aa.aa

+29.07%

-388.17%

+14.99%

+37.92%

-22.56%

EBIT Margin %

aa.aa

-53.42%

-152.01%

-559.79%

-378.66%

-384.37%

Net Interest Expenses

aa.aa

2.17

0.97

0.96

0.38

-0.43

Net Interest Expenses Growth

aa.aa

+44.53%

-55.07%

-1.44%

-60.94%

-215.47%

Interest Expense, Total

aa.aa

-0.23

-0.32

-0.98

-2.2

-4.01

Interest And Investment Income

aa.aa

2.39

1.29

1.94

2.58

3.58

Other Non Operating Expenses, Total

aa.aa

9.26

18.36

4.83

-14.81

21.14

EBT, Excl. Unusual Items

aa.aa

-47.25

-267.09

-237.69

-165.57

-164.54

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-47.25

-267.09

-237.69

-165.57

-164.54

EBT, Incl. Unusual Items Growth

aa.aa

+36.54%

-465.31%

+11.01%

+30.34%

+0.63%

EBT, Incl. Unusual Items Margin

aa.aa

-43.02%

-141.75%

-546.49%

-414.81%

-341.41%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-47.25

-267.09

-237.69

-165.57

-164.54

Minority Interest

aa.aa

19.12

13.95

8.03

0.19

Net Income

aa.aa

-47.25

-247.96

-223.74

-157.55

-164.35

Net Income Growth

aa.aa

+36.54%

-424.83%

+9.77%

+29.59%

-4.32%

Net Income Margin %

aa.aa

-43.02%

-131.6%

-514.42%

-394.7%

-341.01%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-47.25

-247.96

-223.74

-157.55

-164.35

Basic EPS - Continuing Operations

aa.aa

-0.79

-3.88

-3.4

-2.2

-2.28

Basic EPS - Continuing Operations Growth

aa.aa

+43.59%

-393.06%

+12.42%

+35.22%

-3.43%

Diluted EPS - Continuing Operations

aa.aa

-0.79

-3.88

-3.4

-2.2

-2.28

Diluted EPS - Continuing Operations Growth

aa.aa

+43.57%

-391.45%

+12.42%

+35.22%

-3.51%

Basic Weighted Average Shares Outstanding

aa.aa

63.87

65.8

71.52

72.13

Diluted Weighted Average Shares Outstanding

aa.aa

63.87

65.8

71.52

72.13

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-50.19

-280.06

-237.71

-145.53

-179.22

EBITDA Growth

aa.aa

+33.77%

-458.06%

+15.12%

+38.78%

-23.15%

EBITDA Margin %

aa.aa

-45.7%

-148.64%

-546.53%

-364.6%

-371.87%

EBIT

aa.aa

-58.67

-286.42

-243.48

-151.14

-185.24

* In Millions of TWD (except for per share items)

S&P/TSX

35,620.03

-629.00

-1.74%

S&P/TSX 60

2,125.02

-31.76

-1.47%

US 30

51,788.50

-554.1

-1.06%

US 500

7,580.90

-139.3

-1.80%

S&P 500 VIX

19.42

+2.22

+12.91%

DAX

25,818.21

-221.47

-0.85%

Dollar Index

101.83

-0.070

-0.06%

Market Movers

Name	Last	Chg. %	Vol.
RBC	283.93	-1.49%	3.02M
TD	174.04	-2.30%	4.39M
Bank of Montreal	239.22	-2.87%	2.00M
Bank of Nova Scotia	131.05	-1.79%	3.57M
Suncor Energy	111.11	+2.26%	3.70M
Cameco	107.60	-7.74%	3.50M
Imperial Oil	193.48	+5.37%	1.94M

Name	Last	Chg. %	Vol.
Mijem Newcomm Tech	0.10	+375.00%	27.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Ramm Pharma	0.01	+100.00%	200.00K
Champion Electric	0.010	+100.00%	100.00K
First Growth Funds	0.03	+100.00%	70.00K
Canyon Creek	0.0250	+66.67%	7.00K

Name	Last	Chg. %	Vol.
Modern Plant Based Foods	0.070	-61.11%	2.00K
Regenera Insights	0.03	-54.55%	9.00K
Appili Therapeutics	0.0050	-50.00%	18.01K
James Bay Resources Ltd	0.005	-50.00%	35.10K
SP Strategic Acquisition	0.02	-50.00%	3.00K
Nobel Resources	0.02	-50.00%	51.00K
Playground Ventures	0.005	-50.00%	29.01K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	369.32	-6.77%	623.00K
Air Canada	20.19	-7.68%	5.42M
TD	174.04	-2.30%	4.39M
Space Exploration Tech DRC	22.40	-6.35%	1.76M
Telus	12.37	+2.40%	9.03M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa	15.50	+58.23%	24.52
Aaaaaaaa	10.050	+52.84%	15.360
Aaaa Aaaa Aaaaa Aa	37.15	+51.74%	56.37
Aaaaaa Aaaaa Aaa A	8.73	+50.57%	13.15
Aa Aaaaa A	18.27	+50.23%	27.45
Aaaaaaaaaaaaaaaa A	4.60	+49.71%	6.89
Aaaaaaaaaaaaaaaaaa	20.19	+49.08%	30.10

Name	Last	Upside	Fair Value
Aaaaaaa	15.50	+58.23%	24.52
Aaaaaaaa	10.050	+52.84%	15.360
Aaaa Aaaa Aaaaa Aa	37.15	+51.74%	56.37
Aaaaaa Aaaaa Aaa A	8.73	+50.57%	13.15
Aa Aaaaa A	18.27	+50.23%	27.45
Aaaaaaaaaaaaaaaa A	4.60	+49.71%	6.89
Aaaaaaaaaaaaaaaaaa	20.19	+49.08%	30.10

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.